Journal of Public Health and Epidemiology
Subscribe to JPHE
Full Name*
Email Address*

Article Number - E31A54F66930

Vol.10(1), pp. 16-20 , January 2018
DOI: 10.5897/JPHE2016.0942
ISSN: 2141-2316

Full Length Research Paper

The characteristics of benign prostatic hyperplasia (BPH) in Rumah Sakit Umum Haji Medan

Shahrul Rahman
  • Shahrul Rahman
  • Department of Internal Medicine, Medical Faculty, University Muhammadiyah Sumatera Utara, Medan, Indonesia.
  • Google Scholar

 Received: 22 April 2017  Accepted: 25 October 2017  Published: 31 January 2018

Copyright © 2018 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0

Benign prostatic hyperplasia (BPH) is an enlarged prostate gland caused by progressive hyperplasia of glandular cells or stoma cells from prostate tissues. BPH is a common problem that increases in people from 40 years old. The symptom is lower urinary tract symptoms (LUTS) that consist of the followings: Strenuous urination, frequent urination, urinary hesitancy and retention. This study aims to know the characteristic of BPH patients in RSU Haji Medan from January to December 2015. Research design of this study is descriptive studies. The population of the study consists of patients who were diagnosed with BPH in RSU Haji Medan from January to December 2015. Total sampling method was used. Research data were retrieved by taking the patients’ entire medical record with BPH in RSU Haji Medan from January to December 2015. 84 persons were diagnosed with BPH. The highest age group of the population is 60 to 70 years (34 people (40.5%). The most common complaint of the patients with BPH is the inability to urinate (42 people (50.0%). Common volume size of prostate is 40 to 60 g (people (38.1%). The most common therapy is transurethral resection of the prostate (TURP) (people (76.2%). The highest co morbidity is hypertension (20 people (23.8%). The patients that had BPH most in RSU Haji Medan were 60 to 70 years old; the chief complaint is not being able to urinate; common size of prostate volume is 40 to 60 g; the most common therapy that is used is TURP, and the highest co morbidity is hypertension.

Key words: Benign prostatic hyperplasia (BPH), older group, transurethral resection of the prostate (TURP), hypertension.

Amalia R (2010). Risk Factors in occurrence of Benign Prostate Enlargement (Case Study on RS Kariadi, RSI Sultan Agung, Semarang Roemani RS). Semarang: Diponegoro University School of Medicine.


Arif M (2007). Medicine Capita Selecta. 6thEdition. Editor Suprohaita. Jakarta. Media Aescalapius. FK UI: pp. 329-330.


Association of Indonesia's Urologists (2009). Guidelines for Management of BPH in Indonesia. Available from:

View. [Accessed 9Mei 2016] pp. 1-15.


Fjellestad-Paulsen A, Höglund P, Lundin S, Paulsen O (1993). Pharmacokinetics of 1-deamino-8-D-arginine vasopressin after various routes of administration in healthy volunteers. Clin. Endocrinol. 38(2):177-182.


Fowler C, McAllister W, Plail R, Karim O, Yang Q (2005). Randomized evaluation of alternative electrosurgical modalities to treat bladder outflow obstruction in men with benign prostatic hyperplasia. Health Technol. Assess 9:3-4, 1-30.


Glina S, Felipe G (2013). Phatogenic mechanism linking benign prostatic hyperplasia, lower urinary tract symptoms and erectile dysfunction. Therapeutic Advances in Urology. 5(4):211-8.


Gravas S, Bachmann A, Descazeaud A, Drake M, Gratzke C, Madersbacher S, Mamoulakis C, Oelke M, Tikkinen KAO (2015). Guidelines on the management of non-neurogenic male lower urinary tract symptoms (LUTS), incl. Benign Prostatic Obstruction (BPO). European Association of Urolog. 


Hindley RG, Mostafid AH, Brierly RD, Harrison NW, Thomas PJ, Fletcher MS. (2001). The 2-year symptomatic and urodynamic results of a prospective randomized trial of interstitial radiofrequency therapy vs transurethral resection of the prostate. BJU Int. 88:217-220.


January 2012-December 2013. Medan: Faculty of Medicine, University of North Sumatra.


Kuspriyanti NP (2015). The comparison of genesis urolithiasis based on the Characteristics of patients with benign prostatic hyperplasia. Bandung: Bandung Islamic University School of Medicine.


Madersbacher S, Schatzl G, Djavan B, Stulnig T, Marberger M (2000). Long-term outcome of transrectal high- intensity focused ultrasound therapy for benign prostatic hyperplasia. Eur. Urol. 37:687-694.


Nickel JC, Mendez CE, Whelan TF, Paterson RF, Razvi H (2010). Update: Guidelines for the management of benign prostatic hyperplasia. Can. Urol. Assoc. J. 4(5):310-316.


Presti JC (2016). Benign Prostatic Hyperplasia incidence and epidemiology [Accessed May 10, 2016]


Presti JC, Kane CJ, Shinohara K, Carroll PR (2008). Neoplasms of the Prostate Gland.In: Tanogho, E.A., McAninch, J.W., Smith's General Urology. 17th Ed. USA: Lange, 348:350-351.


Purnomo BB (2011). Fundamentals of Urology. 3rd Edition. Jakarta: Sagung Seto. 51-55, 57, 75, 124, 127, 129-131.


Rembratt A, Graugaard-Jensen C, Senderovitz T, Norgaard JP, Djurhuus JC (2004). Pharmacokinetics and pharmacodynamics of desmopressin administered orally versus intravenously at daytime versus night-time in healthy men aged 55-70 years. Eur. J. Clin. Pharmacol. 60(6):397-402.


Roar JK (2015). The Characteristics of Patients with Benign Prostate Hyperplasia (BPH) Undergoing Transurethral Resection of the Prostate (TURP) in the General Hospital Haji Adam Malik in period of Roehrborn CG, Nuckolls JG, Wei JT, Steers W (2007). BPH registry and patient survey steering committee. The benign prostatic hyperplasia registry and patient survey: Study design, methods and patient baseline characteristics. BJU Int. 100:813-819.


Tanagho E (2008). Smith's General Urology. 17. Issue Editor Jacle W. USA: The McGraw Hill Companies. P 574.


Vesely S, Knutson T, Damber JE, Dicuio M. Dahlstrand C (2006). TURP and low energy TUMT treatment in men with LUTS suggestive of bladder outlet obstruction elected by means of pressure-flow studies: 8-year follow-up. Neur. Urodyn, 25:770-775.



APA Rahman, S. (2018). The characteristics of benign prostatic hyperplasia (BPH) in Rumah Sakit Umum Haji Medan. Journal of Public Health and Epidemiology, 10(1), 16-20.
Chicago Shahrul Rahman. "The characteristics of benign prostatic hyperplasia (BPH) in Rumah Sakit Umum Haji Medan." Journal of Public Health and Epidemiology 10, no. 1 (2018): 16-20.
MLA Shahrul Rahman. "The characteristics of benign prostatic hyperplasia (BPH) in Rumah Sakit Umum Haji Medan." Journal of Public Health and Epidemiology 10.1 (2018): 16-20.
DOI 10.5897/JPHE2016.0942

Subscription Form